Medical

oxidative deamination

Also found in: Dictionary, Wikipedia.

ox·i·da·tive de·am·i·na·tion

deamination by enzymes that uses flavin or pyridine nucleotides (such as FAD or NAD+).
Farlex Partner Medical Dictionary © Farlex 2012

oxidative deamination

a deamination that also involves an oxidation, for example, an alpha amino acid to an alpha keto acid.
Collins Dictionary of Biology, 3rd ed. © W. G. Hale, V. A. Saunders, J. P. Margham 2005
Mentioned in
References in periodicals archive
Other minor phase I reactions included isopropyl hydroxylation (F3, F5), A-depentylation (F4), oxidative deamination of the carboxamide group (F10-F12), and isopropyl dehydrogenation (F11, F12).
F10, F11, and F12 were minor third and fourth generation metabolites combining oxidative defluorination and subsequent carboxylation and oxidative deamination (F10), oxidative defluorination, oxidative deamination, and isopropyl dehydrogenation (F11) and oxidative defluorination and subsequent carboxylation, oxidative deamination, and isopropyl dehydrogenation (F12).
Monoamine oxidases (MAOs) are flavoproteins which catalyze the oxidative deamination of a variety of neurotransmitters, such as noradrenaline, dopamine, and serotonin, as well as different exogenous and endogenous amines (i.e., tyramine, benzylamine, etc.) to their corresponding aldehydes.
3,4-Dihydroxyphenylacetaldehyde (DOPAL) is an endogenous catecholaldehyde produced by oxidative deamination of dopamine.
VMA may also be produced by the oxidative deamination of normetanephrine and metanephrine or by O-methylation of dihydroxymandelic acid, a minor metabolite of norepinephrine (2,3).
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.